High Omega-3/Low Omega-6 Treatment Diet for Aspirin-exacerbated Respiratory Disease (AERD)
A Pilot Study of the Effectiveness of a High Omega-3/Low Omega-6 Treatment Diet for Treating Aspirin-exacerbated Respiratory Disease
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Brigham and Women's Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- History of physician-diagnosed asthma
- History of nasal polyposis
- History of at least two reactions to oral aspirin or other nonselective cyclooxygenase inhibitor with features of lower airway involvement (cough, chest tightness, wheezing, dyspnea), or diagnosis of AERD via a physician-conducted challenge to aspirin
- Age between 18 and 70 years
Exclusion Criteria:
- Current smoking, defined as daily tobacco smoking in the last 6 months and at least one instance of tobacco smoking in the last 3 months.
- Current pregnancy or breastfeeding
- BMI <20
- History of allergy to fish or any unwillingness to eat fish as a regular part of the diet
- Use of Zyflo (zileuton) in the last two weeks
- Presence of an implantable cardioverter-defibrillator
- Use of oral steroids in the last two weeks
- Participation in any other clinical trial in the last month
- Any use of nonsteroidal antiinflammatory drugs (NSAIDs) or any drug that inhibits the cyclooxygenase enzyme during the course of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Normal diet
Two weeks of unaltered diet
|
|
|
Experimental: Low omega-6/high omega-3 diet
Restricting daily intake of omega-6 fatty acids to less than 4 grams and increasing omega-3 fatty acids to 3 grams
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in urinary leukotriene E4 levels
Time Frame: 2 weeks and 4 weeks
|
2 weeks and 4 weeks
|
|
Change in serum leukotriene B4 levels
Time Frame: 2 weeks and 4 weeks
|
2 weeks and 4 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in asthma control questionnaire score
Time Frame: Baseline, 2 weeks, and 4 weeks
|
Baseline, 2 weeks, and 4 weeks
|
|
Change in Sino-Nasal Outcome Test-22 (SNOT-22) score
Time Frame: Baseline, 2 weeks, and 4 weeks
|
Baseline, 2 weeks, and 4 weeks
|
|
Change in forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and FEV1/FVC
Time Frame: Baseline, two weeks, and four weeks
|
Baseline, two weeks, and four weeks
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in urinary prostaglandin D2 level
Time Frame: 2 weeks and 4 weeks
|
2 weeks and 4 weeks
|
|
Change in blood eosinophil count
Time Frame: 2 weeks and 4 weeks
|
2 weeks and 4 weeks
|
|
Change in platelet-leukocyte aggregates
Time Frame: 2 weeks and 4 weeks
|
2 weeks and 4 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2013-P002683
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.